Amgo Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Amgo Therapeutics
Amgo Therapeutics Private Limited (ATPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2019 (Five years and ten months 27 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Kyntox Agrovet India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swetha Peddasetty, Gopi Kadiyala, and Abheepsa Mishra serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KA2019PTC122747
- Company No.
122747
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Amgo Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopi Kadiyala  | Director | 27-Mar-2019 | Current |
| Swetha Peddasetty | Director | 27-Mar-2019 | Current |
| Abheepsa Mishra | Director | 18-Aug-2021 | Current |
Financial Performance of Amgo Therapeutics.
Amgo Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amgo Therapeutics?
Unlock access to Amgo Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kyntox Biotech India Private LimitedSwetha Peddasetty and Gopi Kadiyala are mutual person
Sanovida Biosciences Private LimitedSwetha Peddasetty and Gopi Kadiyala are mutual person
- Utopia Therapeutics Private Limited
Gopi Kadiyala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amgo Therapeutics?
Unlock and access historical data on people associated with Amgo Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amgo Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amgo Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.